alpha-aminopyridine has been researched along with g(m1) ganglioside in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Aureli, M; Bassi, R; Cabrini, G; Chiricozzi, E; Dechecchi, MC; Lippi, G; Loberto, N; Mancini, G; Mauri, L; Olioso, D; Pedemonte, N; Pesce, E; Schiumarini, D; Sonnino, S; Tamanini, A | 1 |
1 other study(ies) available for alpha-aminopyridine and g(m1) ganglioside
Article | Year |
---|---|
GM1 as Adjuvant of Innovative Therapies for Cystic Fibrosis Disease.
Topics: Adjuvants, Immunologic; Aminophenols; Aminopyridines; Benzodioxoles; Bronchi; Chloride Channel Agonists; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Cells; G(M1) Ganglioside; Humans; Mutation; Quinolones; Therapies, Investigational | 2020 |